Table 1.
Studies of Gender Differences in Major Depression Diagnoses
Study | OR | Country | NM | NF | Interview | Year | Age | Sample | E | F | M | T |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Alaimo et al. (2002) | 2.38 | US | 365 | 389 | DIS | 1991 | 15–16 | Third National Health and Nutrition Examination Survey (NHANES III) | 1 | 1 | 2 | 4 |
Andrews et al. (2001)* | 2.40 | Australia | 461 | 608 | CIDI 2.1 | 1997 | 18–24 | Australian National Survey of Mental Health & Well-Being (NSMHWB) | 3 | 1 | 3 | |
Andrews et al. (2001)* | 1.97 | Australia | 940 | 1249 | CIDI 2.1 | 1997 | 25–34 | NSMHWB | 3 | 1 | 3 | |
Andrews et al. (2001)* | 1.97 | Australia | 1131 | 1349 | CIDI 2.1 | 1997 | 35–44 | NSMHWB | 3 | 1 | 3 | |
Andrews et al. (2001)* | 1.69 | Australia | 815 | 1017 | CIDI 2.1 | 1997 | 45–54 | NSMHWB | 3 | 1 | 3 | |
Andrews et al. (2001)* | 2.14 | Australia | 627 | 652 | CIDI 2.1 | 1997 | 55–64 | NSMHWB | 3 | 1 | 3 | |
Andrews et al. (2001)* | 2.78 | Australia | 731 | 1061 | CIDI 2.1 | 1997 | 65+ | NSMHWB | 3 | 1 | 3 | |
Arokiasamy et al. (2013) | 1.24 | India | 3302 | 3255 | CIDI | 2008 | 50+ | WHO Study on global Aging and adult health (SAGE) - India | 3 | 3^ | 3 | |
Arokiasamy et al. (2013) | 1.41 | India | 1042 | 3620 | CIDI | 2008 | 18–49 | WHO SAGE- India | 3 | 3^ | 3 | |
Avenevoli et al. (2015)* | 1.65 | US | 843 | 809 | WMH-CIDI | 2002 | 13 | National Comorbidity Survey- Adolescent Supplement (NCS- A) | 1 | 2 | 1 | 3 |
Avenevoli et al. (2015)* | 5.50 | US | 1088 | 1130 | WMH-CIDI | 2002 | 14 | NCS- A | 1 | 2 | 1 | 3 |
Avenevoli et al. (2015)* | 2.57 | US | 883 | 1004 | WMH-CIDI | 2002 | 15 | NCS- A | 1 | 2 | 1 | 3 |
Avenevoli et al. (2015)* | 2.44 | US | 966 | 1044 | WMH-CIDI | 2002 | 16 | NCS- A | 1 | 2 | 1 | 3 |
Avenevoli et al. (2015)* | 1.93 | US | 1173 | 1183 | WMH-CIDI | 2002 | 17–18 | NCS- A | 1 | 2 | 1 | 3 |
Beals et al. (2005) | 1.79 | US | 606 | 817 | CIDI | 1998 | 15–54 | The American Indian Service Utilization, Psychiatric Epidemiology, Risk & Protective Factors Project (AI-SUPERPFP)- Southwest Tribe | 6 | 2 | 2 | 3 |
Beals et al. (2005) | 1.94 | US | 778 | 840 | CIDI | 1998 | 15–54 | AI-SUPERPFP- Northern Plains Tribe | 6 | 2 | 2 | 3 |
Bijl et al. (1998) | 1.90 | Netherlands | 3304 | 3772 | CIDI 1.1 | 1996 | 18–64 | Netherlands Mental Health Survey & Incidence Study (NEMESIS) | 2 | 2 | 3 | |
Boyd et al. (2015) | 2.55 | Bulgaria | 2430 | 2888 | WMH-CIDI | 2005 | 18+ | Bulgaria National Survey of Health & StressW | 1 | 1 | 4 | |
Boyd et al. (2015) | 1.67 | Romania | 1092 | 1265 | WMH-CIDI | 2006 | 18+ | Romania Mental Health SurveyW | 1 | 1 | 4 | |
Boyd et al. (2015) | 2.44 | Portugal | 1632 | 2217 | WMH-CIDI | 2009 | 18+ | Portugal National Mental Health SurveyW | 1 | 1 | 4 | |
Boyd et al. (2015) | 1.96 | France | 1329 | 1565 | WMH-CIDI | 2002 | 18+ | ESEMeDW | 1 | 1 | 4 | |
Bromet et al. (2005)* | 3.58 | Ukraine | 462 | 608 | WMH-CIDI | 2002 | 18–32 | Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD)W | 2 | 1 | 3 | |
Bromet et al. (2005)* | 2.31 | Ukraine | 443 | 728 | WMH-CIDI | 2002 | 33–47 | CMDPSDW | 2 | 1 | 3 | |
Bromet et al. (2005)* | 2.07 | Ukraine | 440 | 876 | WMH-CIDI | 2002 | 48–62 | CMDPSDW | 2 | 1 | 3 | |
Bromet et al. (2005)* | 2.07 | Ukraine | 447 | 876 | WMH-CIDI | 2002 | 63+ | CMDPSDW | 2 | 1 | 3 | |
Bromet et al. (2011) | 1.57 | Belgium | 1190 | 1229 | WMH-CIDI | 2002 | 18+ | The European Study of the Epidemiology of Mental Disorders (ESEMeD)W | 2 | 1 | 3 | |
Bromet et al. (2011) | 1.71 | Germany | 1660 | 1895 | WMH-CIDI | 2003 | 18+ | ESEMeDW | 2 | 1 | 3 | |
Bromet et al. (2011) | 1.60 | Israel | 2380 | 2479 | WMH-CIDI | 2003 | 21+ | Israel National Health SurveyW | 2 | 1 | 3 | |
Bromet et al. (2011) | 2.54 | Italy | 2321 | 2391 | WMH-CIDI | 2002 | 18+ | ESEMeDW | 2 | 1 | 3 | |
Bromet et al. (2011) | 2.32 | Netherlands | 1032 | 1340 | WMH-CIDI | 2003 | 18+ | ESEMeDW | 2 | 1 | 3 | |
Bromet et al. (2011) | 1.96 | Colombia | 1700 | 2726 | WMH-CIDI | 2003 | 18–65 | Colombian National Study of Mental HealthW | 2 | 1 | 3 | |
Bromet et al. (2011) | 2.11 | Lebanon | 1297 | 1560 | WMH-CIDI | 2003 | 18+ | Lebanese Evaluation of the Burden of Ailments and Needs of the NationW | 2 | 1 | 3 | |
Bromet et al. (2011) | 2.17 | South Africa | 1718 | 2597 | WMH-CIDI | 2004 | 18+ | South Africa Stress and Health StudyW | 2 | 1 | 3 | |
Center for Behavioral Health Statistics & Quality (CBHSQ) (2014) | 2.86 | US | 11363 | 10938 | WMH-CIDI | 2004 | 12–17 | National Survey on Drug Use & Health (NSDUH) | 1 | 1 | 3 | |
CBHSQ (2014) | 3.26 | US | 11378 | 11156 | WMH-CIDI | 2005 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.05 | US | 11718 | 11153 | WMH-CIDI | 2006 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.80 | US | 11524 | 10909 | WMH-CIDI | 2007 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.18 | US | 11517 | 11029 | WMH-CIDI | 2008 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.69 | US | 11520 | 11106 | WMH-CIDI | 2009 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.93 | US | 11140 | 10820 | WMH-CIDI | 2010 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.92 | US | 12028 | 11482 | WMH-CIDI | 2011 | 12–17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.66 | US | 1918 | 1807 | WMH-CIDI | 2012 | 12 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 5.22 | US | 1840 | 1838 | WMH-CIDI | 2012 | 13 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.28 | US | 1883 | 1872 | WMH-CIDI | 2012 | 14 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.98 | US | 1921 | 1817 | WMH-CIDI | 2012 | 15 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.71 | US | 1937 | 1878 | WMH-CIDI | 2012 | 16 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.66 | US | 1877 | 1885 | WMH-CIDI | 2012 | 17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.14 | US | 1824 | 1713 | WMH-CIDI | 2013 | 12 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.76 | US | 1963 | 1849 | WMH-CIDI | 2013 | 13 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 4.95 | US | 2026 | 1865 | WMH-CIDI | 2013 | 14 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.98 | US | 1882 | 1868 | WMH-CIDI | 2013 | 15 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.92 | US | 1940 | 1890 | WMH-CIDI | 2013 | 16 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.12 | US | 1914 | 1760 | WMH-CIDI | 2013 | 17 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.99 | US | 10774 | 11755 | WMH-CIDI | 2012 | 18–25 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.89 | US | 1469 | 1593 | WMH-CIDI | 2012 | 26–29 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.13 | US | 1559 | 1863 | WMH-CIDI | 2012 | 30–34 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.39 | US | 1365 | 1537 | WMH-CIDI | 2012 | 35–39 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.69 | US | 1394 | 1615 | WMH-CIDI | 2012 | 40–44 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.73 | US | 1428 | 1737 | WMH-CIDI | 2012 | 45–49 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.35 | US | 816 | 1013 | WMH-CIDI | 2012 | 50–54 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.45 | US | 722 | 877 | WMH-CIDI | 2012 | 55–59 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.76 | US | 598 | 736 | WMH-CIDI | 2012 | 60–65 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.09 | US | 1360 | 1625 | WMH-CIDI | 2012 | 65+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 2.09 | US | 10671 | 11543 | WMH-CIDI | 2013 | 18–25 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.80 | US | 1376 | 1603 | WMH-CIDI | 2013 | 26–29 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.29 | US | 1529 | 1802 | WMH-CIDI | 2013 | 30–34 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.67 | US | 1317 | 1562 | WMH-CIDI | 2013 | 35–39 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.63 | US | 1437 | 1671 | WMH-CIDI | 2013 | 40–44 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.34 | US | 1440 | 1631 | WMH-CIDI | 2013 | 45–49 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.47 | US | 837 | 951 | WMH-CIDI | 2013 | 50–54 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.61 | US | 711 | 909 | WMH-CIDI | 2013 | 55–59 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.42 | US | 674 | 719 | WMH-CIDI | 2013 | 60–65 | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 3.55 | US | 1302 | 1659 | WMH-CIDI | 2013 | 65+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.90 | US | 21408 | 24366 | WMH-CIDI | 2005 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.75 | US | 20995 | 23936 | WMH-CIDI | 2006 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.91 | US | 21272 | 24165 | WMH-CIDI | 2007 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.88 | US | 21602 | 24588 | WMH-CIDI | 2008 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.77 | US | 21755 | 24319 | WMH-CIDI | 2009 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.73 | US | 21697 | 24147 | WMH-CIDI | 2010 | 18+ | NSDUH | 1 | 1 | 3 | |
CBHSQ (2014) | 1.84 | US | 21750 | 24489 | WMH-CIDI | 2011 | 18+ | NSDUH | 1 | 1 | 3 | |
Chan Chee et al. (2011) | 2.28 | France | 529 | 596 | CIDI-SF | 2005 | 15–19 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 1.98 | France | 1813 | 2417 | CIDI-SF | 2005 | 20–34 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 2.46 | France | 2655 | 3690 | CIDI-SF | 2005 | 35–54 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 1.95 | France | 2081 | 3102 | CIDI-SF | 2005 | 55–75 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 2.02 | France | 878 | 1060 | CIDI-SF | 2010 | 20–34 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 1.52 | France | 1433 | 1725 | CIDI-SF | 2010 | 35–54 | French Barometer Study | 2 | 1 | 3 | |
Chan Chee et al. (2011) | 2.65 | France | 1122 | 1527 | CIDI-SF | 2010 | 55–75 | French Barometer Study | 2 | 1 | 3 | |
Cho et al. (2010)* | 2.40 | South Korea | 560 | 683 | K-CIDI 2.1 | 2007 | 18–29 | Korean National Epidemiologic Catchment Area Study- Replication (KECA-R) | 2 | 1 | 3 | |
Cho et al. (2010)* | 2.55 | South Korea | 688 | 1136 | K-CIDI 2.1 | 2007 | 30–39 | KECA-R | 2 | 1 | 3 | |
Cho et al. (2010)* | 1.26 | South Korea | 690 | 1065 | K-CIDI 2.1 | 2007 | 40–49 | KECA-R | 2 | 1 | 3 | |
Cho et al. (2010)* | 1.85 | South Korea | 431 | 683 | K-CIDI 2.1 | 2007 | 50–59 | KECA-R | 2 | 1 | 3 | |
Cho et al. (2007) | 3.18 | South Korea | 3524 | 2751 | K-CIDI 2.1 | 2001 | 18–64 | KECA | 2 | 1 | 3 | |
Coyne & Marcus (2006) | 2.15 | US | 11612 | 14903 | CIDI-SF | 1999 | 18+ | National Health Interview Survey | 2 | 2 | 1 | 3 |
Coyne & Marcus (2006) | 2.29 | US | 1590 | 2696 | CIDI-SF | 1999 | 18+ | National Health Interview Survey | 3 | 2 | 1 | 3 |
Danielson et al. (2005). | 1.98 | US | 2020 | 2003 | NSA interview | 1995 | 12–17 | National Survey of Adolescents (NSA) | 1 | 2 | 1 | 3 |
de Graaf et al. (2012) | 1.57 | Netherlands | 2977 | 3669 | WMH-CIDI | 2008 | 18–64 | NEMESIS II | 2 | 1 | 3 | |
Farbstein et al. (2010) | 2.55 | Israel | 497 | 460 | DAWBA | 2005 | 14–17 | Israel Survey of Mental Health among Adolescents (ISMEHA) | 3 | 1 | 2 | |
Ford et al. (2003)* | 1.51 | Great Britain | 1284 | 1340 | DAWBA | 1999 | 13–15 | British Child & Adolescent Mental Health Survey | 2 | 1 | 0 | |
Gabilondo et al. (2010). | 2.83 | Spain | 733 | 834 | WMH-CIDI | 2002 | 18–34 | ESEMeDW | 2 | 1 | 3 | |
Gabilondo et al. (2010). | 1.82 | Spain | 622 | 809 | WMH-CIDI | 2002 | 35–49 | ESEMeDW | 2 | 1 | 3 | |
Gabilondo et al. (2010). | 2.83 | Spain | 437 | 587 | WMH-CIDI | 2002 | 50–64 | ESEMeDW | 2 | 1 | 3 | |
Gabilondo et al. (2010). | 6.29 | Spain | 629 | 822 | WMH-CIDI | 2002 | 65+ | ESEMeDW | 2 | 1 | 3 | |
Gavin et al. (2009) | 1.92 | US | 1217 | 2217 | WMH-CIDI | 2002 | 18+ | National Survey of American Life | 3 | 2 | 1 | 4 |
Goodwin & Gotlib (2004) | 1.75 | US | 1492 | 1540 | CIDI-SF | 1996 | 25–74 | MIDUS (Midlife in the US) | 1 | 1 | 2 | 3 |
Graham et al. (2007) | 2.06 | Canada | 6214 | 7878 | CIDI | 2005 | 18–76 | Gender Alcohol and Culture: An International Study (GENACIS) | 2 | 1 | 3 | |
Grant (1995) | 1.31 | US | 21431 | 21431 | AUDADIS | 1992 | 18+ | National Longitudinal Alcohol Epidemiologic Survey (NLAES) | 1 | 2 | 1 | 4 |
Gureje et al. (2006)* | 0.83 | Nigeria | 1595 | 1580 | WMH-CIDI | 2003 | 18–34 | Nigerian Survey of Mental Health & Wellbeing (NSMHW)W | 2 | 1 | 3 | |
Gureje et al. (2006)* | 1.84 | Nigeria | 809 | 822 | WMH-CIDI | 2003 | 35–49 | NSMHWW | 2 | 1 | 3 | |
Gureje et al. (2006)* | 1.28 | Nigeria | 503 | 601 | WMH-CIDI | 2003 | 50–64 | NSMHWW | 2 | 1 | 3 | |
Haarasilta et al. (2001) | 1.36 | Finland | 437 | 505 | CIDI-SF | 1996 | 15–24 | Finnish Health Care Survey (FINHCS) | 2 | 2 | 3 | |
Hasin et al. (2005)* | 1.93 | US | 2410 | 2789 | AUDADIS | 2002 | 18–24 | National Epidemiologic Survey on Alcohol & Related Conditions (NESARC) | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 2.08 | US | 1407 | 2060 | AUDADIS | 2002 | 25–29 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 3.28 | US | 1834 | 2458 | AUDADIS | 2002 | 30–34 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 1.65 | US | 1989 | 2661 | AUDADIS | 2002 | 35–39 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 2.36 | US | 2034 | 2406 | AUDADIS | 2002 | 40–44 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 1.84 | US | 1876 | 2142 | AUDADIS | 2002 | 45–49 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 2.53 | US | 1603 | 2004 | AUDADIS | 2002 | 50–54 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 1.76 | US | 1236 | 1611 | AUDADIS | 2002 | 55–59 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 1.41 | US | 1025 | 1343 | AUDADIS | 2002 | 60–64 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 2.38 | US | 927 | 1255 | AUDADIS | 2002 | 65–69 | NESARC | 1 | 2 | 1 | 3 |
Hasin et al. (2005)* | 1.74 | US | 2177 | 3846 | AUDADIS | 2002 | 70 + | NESARC | 1 | 2 | 1 | 3 |
Instituto Nacional de Salud Publica (2014) | 6.02 | Mexico | 1028 | 1176 | CIDI | 2010 | 50+ | WHO SAGE- Mexico | 3 | 3^ | 3 | |
Joe et al. (2009)* | 0.98 | US | 563 | 607 | WMH-CIDI | 2002 | 13–17 | National Survey of American Life | 3 | 3 | 1 | 3 |
Kessler et al. (2010) | 2.03 | US | 1375 | 1658 | WMH- CIDI | 2002 | 18–34 | National Comorbidity Survey- Replication (NCS- R)W | 1 | 2 | 1 | 3 |
Kessler et al. (2010) | 1.59 | US | 1343 | 1522 | WMH- CIDI | 2002 | 35–49 | NCS-RW | 1 | 2 | 1 | 3 |
Kessler et al. (2010) | 1.54 | US | 854 | 1068 | WMH- CIDI | 2002 | 50–64 | NCS-RW | 1 | 2 | 1 | 3 |
Kessler et al. (2010) | 3.16 | US | 567 | 894 | WMH- CIDI | 2002 | 65+ | NCS-RW | 1 | 2 | 1 | 3 |
Kessler et al. (1993) | 1.86 | US | 838 | 927 | CIDI | 1991 | 15–24 | National Comorbidity Survey (NCS) | 1 | 1 | 2 | 3 |
Kessler et al. (1993) | 1.53 | US | 1246 | 1378 | CIDI | 1991 | 25–34 | NCS | 1 | 1 | 2 | 3 |
Kessler et al. (1993) | 1.65 | US | 1065 | 1178 | CIDI | 1991 | 35–44 | NCS | 1 | 1 | 2 | 3 |
Kessler et al. (1993) | 2.97 | US | 696 | 770 | CIDI | 1991 | 45–54 | NCS | 1 | 1 | 2 | 3 |
Kiejna et al. (2015) | 1.82 | Poland | 1465 | 1430 | WMH-CIDI | 2011 | 18–29 | Epidemiology of Mental Health and Access to Care Survey (EZOP)W | 1 | 1 | 4 | |
Kiejna et al. (2015) | 1.76 | Poland | 1069 | 1050 | WMH-CIDI | 2011 | 30–39 | EZOPW | 1 | 1 | 4 | |
Kiejna et al. (2015) | 2.51 | Poland | 938 | 936 | WMH-CIDI | 2011 | 40–49 | EZOPW | 1 | 1 | 4 | |
Kiejna et al. (2015) | 2.37 | Poland | 1411 | 1782 | WMH-CIDI | 2011 | 50–64 | EZOPW | 1 | 1 | 4 | |
Kim et al. (2015)* | 2.36 | South Korea | 691 | 636 | K-CIDI | 2011 | 18–29 | KECA-2011 | 1 | 1 | 3 | |
Kim et al. (2015)* | 2.02 | South Korea | 655 | 645 | K-CIDI | 2011 | 30–39 | KECA-2011 | 1 | 1 | 3 | |
Kim et al. (2015)* | 2.50 | South Korea | 687 | 682 | K-CIDI | 2011 | 40–49 | KECA-2011 | 1 | 1 | 3 | |
Kim et al. (2015)* | 2.01 | South Korea | 542 | 553 | K-CIDI | 2011 | 50–59 | KECA-2011 | 1 | 1 | 3 | |
Kim et al. (2015)* | 3.40 | South Korea | 315 | 351 | K-CIDI | 2011 | 60–69 | KECA-2011 | 1 | 1 | 3 | |
Kim et al. (2015)* | 3.65 | South Korea | 112 | 149 | K-CIDI | 2011 | 70+ | KECA-2011 | 1 | 1 | 3 | |
Lara et al. (2015) | 1.80 | Spain | 435 | 523 | CIDI | 2012 | 18–49 | Collaborative Research on Aging in Europe (COURAGE)- Spain | 2 | 1 | 3 | |
Lara et al. (2015) | 1.95 | Spain | 829 | 931 | CIDI | 2012 | 50–64 | COURAGE- Spain | 2 | 1 | 3 | |
Lara et al. (2015) | 4.17 | Spain | 814 | 1051 | CIDI | 2012 | 65+ | COURAGE- Spain | 2 | 1 | 3 | |
Lepine et al. (1997) | 1.75 | Belgium | 4032 | 4044 | MINI | 1995 | 18+ | DEPRES (Depression Research in European Society) | 2 | 1 | 2 | |
Lepine et al. (1997) | 2.22 | France | 7162 | 7355 | MINI | 1995 | 15+ | DEPRES | 2 | 1 | 2 | |
Lepine et al. (1997) | 1.58 | Germany | 7798 | 8386 | MINI | 1995 | 14+ | DEPRES | 2 | 1 | 2 | |
Lepine et al. (1997) | 1.97 | Netherlands | 4224 | 3587 | MINI | 1995 | 16+ | DEPRES | 2 | 1 | 2 | |
Lepine et al. (1997) | 2.12 | Spain | 8063 | 8069 | MINI | 1995 | 15+ | DEPRES | 2 | 1 | 2 | |
Lepine et al. (1997) | 1.41 | UK | 7155 | 8588 | MINI | 1995 | 16+ | DEPRES | 2 | 1 | 2 | |
Lorenzo-Blanco et al. (2013) | 1.77 | US | 1127 | 1427 | WMH-CIDI | 2003 | 18+ | National Latino & Asian American Study (NLAAS) | 5 | 1 | 1 | 3 |
Maske et al. (2016)* | 3.69 | Germany | 371 | 413 | M-CIDI | 2011 | 18–34 | Germany Health Interview and Examination Survey for Adults- mental health module (DEGS1-MH) | 2 | 1 | 3 | |
Maske et al. (2016)* | 4.33 | Germany | 291 | 332 | M-CIDI | 2011 | 35–44 | DEGS1-MH | 2 | 1 | 3 | |
Maske et al. (2016)* | 1.41 | Germany | 414 | 524 | M-CIDI | 2011 | 45–54 | DEGS1-MH | 2 | 1 | 3 | |
Maske et al. (2016)* | 1.21 | Germany | 399 | 444 | M-CIDI | 2011 | 55–64 | DEGS1-MH | 2 | 1 | 3 | |
Maske et al. (2016)* | 3.10 | Germany | 628 | 592 | M-CIDI | 2011 | 65–79 | DEGS1-MH | 2 | 1 | 3 | |
McMartin et al. (2013)* | 2.82 | Canada | 3228 | 3078 | CIDI-SF | 2001 | 12–14 | Canadian Community Health Survey (CCHS) | 2 | 1 | 3 | |
McMartin et al. (2013)* | 3.22 | Canada | 5425 | 5380 | CIDI-SF | 2001 | 15–19 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.76 | Canada | 3350 | 3997 | CIDI-SF | 2001 | 20–24 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.88 | Canada | 3914 | 4586 | CIDI-SF | 2001 | 25–29 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.87 | Canada | 4644 | 5306 | CIDI-SF | 2001 | 30–34 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.85 | Canada | 5687 | 6429 | CIDI-SF | 2001 | 35–39 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 2.17 | Canada | 6073 | 6458 | CIDI-SF | 2001 | 40–44 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 2.06 | Canada | 5368 | 5647 | CIDI-SF | 2001 | 45–49 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.45 | Canada | 4759 | 5184 | CIDI-SF | 2001 | 50–54 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 2.23 | Canada | 3867 | 4226 | CIDI-SF | 2001 | 55–59 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.62 | Canada | 3136 | 3782 | CIDI-SF | 2001 | 60–64 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.72 | Canada | 2988 | 3625 | CIDI-SF | 2001 | 65–69 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.91 | Canada | 2607 | 3572 | CIDI-SF | 2001 | 70–74 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 2.27 | Canada | 1914 | 3140 | CIDI-SF | 2001 | 75–79 | CCHS 1.1 | 2 | 1 | 3 | |
McMartin et al. (2013)* | 1.54 | Canada | 1783 | 3746 | CIDI-SF | 2001 | 80+ | CCHS 1.1 | 2 | 1 | 3 | |
Merikangas et al. (2012) | 2.98 | US | 2147 | 2003 | NIMH DISC-IV | 2003 | 12–19 | National Health & Nutrition Examination Survey (NHANES), 2001–2004 | 1 | 2 | 1 | 3 |
Mohammadi et al. (2005) | 2.84 | Iran | 12660 | 12530 | SADS | 2001 | 18+ | The national plan for epidemiologic study of psychiatric disorders in Iran | 2 | 1 | 4 | |
Mommersteeg et al. (2013)* | 1.24 | Burkina Faso | 2272 | 2551 | WHO WHS | 2002 | 18+ | World Health Organization (WHO) World Health Survey (WHS) | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.42 | Chad | 2196 | 2447 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.70 | Comoros | 787 | 972 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.64 | Congo | 1167 | 1326 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.11 | Ethiopia | 2391 | 2544 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.67 | Ghana | 1773 | 2153 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.66 | Ivory Coast | 1818 | 1361 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.03 | Kenya | 1868 | 2541 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.17 | Malawi | 2197 | 3033 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.00 | Mali | 2354 | 1711 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.13 | Mauritania | 1465 | 2308 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.41 | Mauritius | 1872 | 2016 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.25 | Namibia | 1721 | 2524 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.01 | Senegal | 1641 | 1515 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 0.93 | Swaziland | 1417 | 1667 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.29 | Tunisia | 2344 | 2725 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.77 | Zimbabwe | 1489 | 2600 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.57 | Brazil | 2188 | 2812 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.94 | Dominican Republic | 2104 | 2430 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.85 | Ecuador | 2051 | 2602 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.48 | Mexico | 16377 | 22368 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 3.39 | Paraguay | 2353 | 2789 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 3.25 | Uruguay | 1449 | 1530 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.82 | Bangladesh | 2584 | 2966 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.01 | China | 1954 | 2039 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.21 | Georgia | 1165 | 1590 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.30 | India | 4849 | 5144 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.65 | Kazakhstan | 1544 | 2951 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.63 | Lao PDR | 2295 | 2594 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.37 | Malaysia | 2673 | 3366 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.01 | Myanmar | 2551 | 3335 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.52 | Nepal | 3698 | 4990 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.34 | Pakistan | 3565 | 2810 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.49 | Philippines | 4659 | 5416 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 0.83 | Sri Lanka | 3136 | 3596 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 0.84 | UAE | 617 | 563 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 7.04 | Vietnam | 1572 | 1919 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 3.82 | Bosnia & Herzegovina | 434 | 594 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.42 | Croatia | 401 | 589 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.46 | Czech Republic | 419 | 516 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.75 | Estonia | 366 | 645 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.57 | Hungary | 591 | 828 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.92 | Russia | 1592 | 2828 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 3.08 | Slovakia | 952 | 1530 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 1.70 | Spain | 2623 | 3740 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
Mommersteeg et al.* | 2.03 | Ukraine | 1001 | 1844 | WHO WHS | 2002 | 18+ | WHO World Health Survey | 2 | 1 | 3 | |
National Research Institute of Public Health, Russian Academy of Medical Science (2013) | 3.02 | Russia | 1520 | 2376 | CIDI | 2009 | 50+ | WHO SAGE- Russia | 3 | 3^ | 3 | |
Patten (2005)* | 2.74 | Canada | 1432 | 1434 | WMH-CIDI | 2002 | 15–19 | Canadian Community Health Survey (CCHS) 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.48 | Canada | 1305 | 1502 | WMH-CIDI | 2002 | 20–24 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 2.20 | Canada | 1074 | 1468 | WMH-CIDI | 2002 | 25–29 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.64 | Canada | 1498 | 1731 | WMH-CIDI | 2002 | 30–34 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.51 | Canada | 1669 | 1860 | WMH-CIDI | 2002 | 35–39 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.80 | Canada | 1775 | 1738 | WMH-CIDI | 2002 | 40–44 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.67 | Canada | 1443 | 1464 | WMH-CIDI | 2002 | 45–49 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 2.69 | Canada | 1282 | 1517 | WMH-CIDI | 2002 | 50–54 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.34 | Canada | 1264 | 1465 | WMH-CIDI | 2002 | 55–59 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 0.89 | Canada | 1092 | 1235 | WMH-CIDI | 2002 | 60–64 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.37 | Canada | 889 | 1184 | WMH-CIDI | 2002 | 65–69 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 1.13 | Canada | 834 | 1206 | WMH-CIDI | 2002 | 70–74 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 0.97 | Canada | 599 | 1042 | WMH-CIDI | 2002 | 75–79 | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 0.22 | Canada | 617 | 1365 | WMH-CIDI | 2002 | 80+ | CCHS 1.2 | 2 | 1 | 3 | |
Patten (2005)* | 3.03 | Canada | 967 | 1057 | WMH-CIDI | 2012 | 15–19 | CCHS- MH (Mental Health) | 2 | 1 | 3 | |
Patten (2005)* | 1.17 | Canada | 923 | 1066 | WMH-CIDI | 2012 | 20–24 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 2.09 | Canada | 737 | 880 | WMH-CIDI | 2012 | 25–29 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 2.00 | Canada | 808 | 1061 | WMH-CIDI | 2012 | 30–34 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.52 | Canada | 827 | 902 | WMH-CIDI | 2012 | 35–39 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.41 | Canada | 877 | 814 | WMH-CIDI | 2012 | 40–44 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.37 | Canada | 795 | 875 | WMH-CIDI | 2012 | 45–49 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 2.04 | Canada | 904 | 1052 | WMH-CIDI | 2012 | 50–54 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.86 | Canada | 1016 | 1229 | WMH-CIDI | 2012 | 55–59 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.57 | Canada | 975 | 1231 | WMH-CIDI | 2012 | 60–64 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 2.31 | Canada | 847 | 1071 | WMH-CIDI | 2012 | 65–69 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 0.39 | Canada | 639 | 793 | WMH-CIDI | 2012 | 70–74 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 1.13 | Canada | 466 | 718 | WMH-CIDI | 2012 | 75–79 | CCHS- MH | 2 | 1 | 3 | |
Patten (2005)* | 5.07 | Canada | 559 | 1024 | WMH-CIDI | 2012 | 80+ | CCHS- MH | 2 | 1 | 3 | |
Peltzer & Phaswana-Mafuya (2013) | 1.08 | South Africa | 1638 | 2202 | WMH-CIDI | 2008 | 50+ | WHO SAGE- South Africa | 2 | 3^ | 3 | |
Pirkola et al. (2005)* | 2.26 | Finland | 983 | 1094 | CIDI | 2001 | 30–44 | Health 2000 | 2 | 1 | 3 | |
Pirkola et al. (2005) | 1.62 | Finland | 768 | 812 | CIDI | 2001 | 45–54 | Health 2000 | 2 | 1 | 3 | |
Pirkola et al. (2005) | 2.10 | Finland | 486 | 563 | CIDI | 2001 | 55–64 | Health 2000 | 2 | 1 | 3 | |
Pirkola et al. (2005) | 2.49 | Finland | 511 | 788 | CIDI | 2001 | 65+ | Health 2000 | 2 | 1 | 3 | |
Rafful et al. (2012) | 1.65 | Mexico | 842 | 1218 | WMH- CIDI | 2002 | 18–29 | Mexico National Comorbidity Survey (M-NCS)W | 1 | 1 | 4 | |
Rafful et al. (2012) | 2.40 | Mexico | 852 | 1384 | WMH- CIDI | 2002 | 30–44 | (M-NCS)W | 1 | 1 | 4 | |
Rafful et al. (2012) | 2.20 | Mexico | 591 | 895 | WMH- CIDI | 2002 | 45–65 | (M-NCS)W | 1 | 1 | 4 | |
Rapsey et al. (2015)* | 1.91 | Iraq | 2091 | 2241 | WMH- CIDI | 2007 | 18–96 | Iraq Mental Health Survey W | 3 | 1 | 4 | |
Sandanger et al. (2007) | 1.55 | Norway | 803 | 888 | CIDI 1.2 | 2001 | 18+ | – | 1 | 1 | 3 | |
Scott et al. (2010)* | 1.61 | New Zealand | 713 | 822 | WMH-CIDI | 2004 | 16–24 | New Zealand Mental Health Survey (NZMHS)W | 2 | 1 | 3 | |
Scott et al. (2010)* | 2.10 | New Zealand | 1000 | 1414 | WMH-CIDI | 2004 | 25–34 | NZMHSW | 2 | 1 | 3 | |
Scott et al. (2010)* | 1.23 | New Zealand | 1231 | 1659 | WMH-CIDI | 2004 | 35–44 | NZMHSW | 2 | 1 | 3 | |
Scott et al. (2010)* | 1.70 | New Zealand | 1023 | 1222 | WMH-CIDI | 2004 | 45–54 | NZMHSW | 2 | 1 | 3 | |
Scott et al. (2010)* | 3.28 | New Zealand | 730 | 934 | WMH-CIDI | 2004 | 55–64 | NZMHSW | 2 | 1 | 3 | |
Scott et al. (2010)* | 3.31 | New Zealand | 937 | 1307 | WMH-CIDI | 2004 | 65+ | NZMHSW | 2 | 1 | 3 | |
Shah et al. (2011) | 1.84 | US | 838 | 927 | DIS | 1991 | 17–39 | NHANES- III | 3 | 2 | 2 | 4 |
Shah et al. (2011) | 2.34 | US | 1246 | 1378 | DIS | 1991 | 17–39 | NHANES- III | 2 | 2 | 2 | 4 |
Shah et al. (2011) | 2.16 | US | 1065 | 1178 | DIS | 1991 | 17–39 | NHANES- III | 5 | 2 | 2 | 4 |
Shanghai Municipal Center for Disease Control and Prevention (2012) | 1.58 | China | 6409 | 6466 | CIDI | 2009 | 50+ | WHO SAGE- China | 3 | 3^ | 3 | |
Skapinakis et al. (2013) | 1.78 | Greece | 2427 | 2467 | CIS-R | 2010 | 18–70 | Psychiatric Morbidity Survey | 2 | 3^ | 1 | |
Slade et al. (2009)* | 2.92 | Australia | 681 | 790 | WMH-CIDI | 2007 | 16–24 | National Survey of Mental Health and Well-Being (NSMHWB)W | 2 | 3^ | 3 | |
Slade et al. (2009)* | 1.57 | Australia | 516 | 774 | WMH-CIDI | 2007 | 25–34 | NSMHWBW | 2 | 3^ | 3 | |
Slade et al. (2009)* | 1.17 | Australia | 756 | 882 | WMH-CIDI | 2007 | 35–44 | NSMHWBW | 2 | 3^ | 3 | |
Slade et al. (2009)* | 1.34 | Australia | 566 | 698 | WMH-CIDI | 2007 | 45–54 | NSMHWBW | 2 | 3^ | 3 | |
Slade et al. (2009)* | 2.80 | Australia | 604 | 669 | WMH-CIDI | 2007 | 55–64 | NSMHWBW | 2 | 3^ | 3 | |
Slade et al. (2009)* | 1.75 | Australia | 904 | 1001 | WMH-CIDI | 2007 | 65–85 | NSMHWBW | 2 | 3^ | 3 | |
Spiers et al. (2012) | 1.60 | England | 4300 | 4318 | CIS-R | 1993 | 16–64 | National Psychiatric Morbidity Surveys (NPMS) | 2 | 3^ | 1 | |
Spiers et al. (2012) | 1.17 | England | 3606 | 3622 | CIS-R | 2000 | 16–71 | NPMS | 2 | 3^ | 1 | |
Spiers et al. (2012) | 1.50 | England | 3454 | 3553 | CIS-R | 2007 | 16–78 | NPMS | 2 | 3^ | 1 | |
Subramaniam et al. (2013)* | 1.43 | Singapore | 1149 | 1144 | WMH-CIDI | 2010 | 18–34 | Singapore Mental Health Study | 2 | 1 | 3 | |
Subramaniam et al. (2013)* | 1.00 | Singapore | 1162 | 1197 | WMH-CIDI | 2010 | 35–49 | Singapore Mental Health Study | 2 | 1 | 3 | |
Subramaniam et al. (2013)* | 3.02 | Singapore | 978 | 976 | WMH-CIDI | 2010 | 50–89 | Singapore Mental Health Study | 2 | 1 | 3 | |
Suttajit et al. (2012)* | 2.26 | Thailand | 1886 | 1786 | MINI | 2008 | 15–24 | Thai National Mental Health survey | 2 | 1 | 4 | |
Suttajit et al. (2012)* | 1.52 | Thailand | 1831 | 1908 | MINI | 2008 | 25–34 | Thai National Mental Health survey | 2 | 1 | 4 | |
Suttajit et al. (2012)* | 1.25 | Thailand | 1904 | 1982 | MINI | 2008 | 35–44 | Thai National Mental Health survey | 2 | 1 | 4 | |
Suttajit et al. (2012)* | 1.57 | Thailand | 2875 | 2968 | MINI | 2008 | 45–59 | Thai National Mental Health survey | 2 | 1 | 4 | |
Takeuchi et al. (2007)* | 0.81 | US | 998 | 1097 | WMH-CIDI | 2003 | 18+ | National Latino & Asian American Study (NLAAS) | 4 | 2 | 1 | 3 |
Toussaint et al. (2008)* | 2.57 | US | 563 | 709 | CIDI-SF | 1998 | 18+ | - | 1 | 1 | 2 | 3 |
University of Ghana Medical School (2013) | 1.72 | Ghana | 2241 | 2041 | CIDI | 2008 | 50+ | WHO SAGE- Ghana | 3 | 3^ | 3 | |
Vicente et al. (2006) | 2.11 | Chile | 1281 | 1697 | CIDI | 1996 | 15+ | Chilean Psychiatric Prevalence Study | 2 | 2 | 3 | |
Volken (2013)* | 1.25 | Switzerland | 7919 | 9936 | CIDI- SF | 2007 | 15+ | Swiss Health Survey | 2 | 1 | 3 | |
Wade et al. (2002) | 1.93 | Canada | 643 | 677 | CIDI-SF | 1995 | 12–19 | National Population Health Survey (NPHS) | 1 | 2 | 3 | |
Wittchen et al. (2000) | 2.17 | Germany | 1913 | 2268 | CIDI | 1998 | 18–65 | German National Health Interview and Examination Survey | 2 | 1 | 3 | |
Zhao et al. (2006) | 2.21 | Canada | 12991 | 14399 | CIDI-SF | 1997 | 20–39 | NPHS | 1 | 2 | 3 | |
Zhao et al. (2006) | 1.91 | Canada | 12386 | 13296 | CIDI-SF | 1997 | 40–64 | NPHS | 1 | 2 | 3 | |
Zinzow et al. (2009)* | 3.24 | US | 923 | 885 | NSA interview | 2005 | 12–14 | National Survey of Adolescents-Replication (NSA-R) | 1 | 2 | 1 | 2 |
Zinzow et al. (2009)* | 2.79 | US | 928 | 868 | NSA interview | 2005 | 15–17 | NSA-R | 1 | 2 | 1 | 2 |
Zubrick et al. (2016)* | 4.96 | Australia | 183 | 160 | DISC-IV | 2014 | 14 | Second Australian Child and Adolescent Survey of Health and Well-being | 2 | 1 | 3 | |
Zubrick et al. (2016)* | 3.16 | Australia | 168 | 141 | DISC-IV | 2014 | 15 | Second Australian Child and Adolescent Survey of Health and Well-being | 2 | 1 | 3 | |
Zubrick et al. (2016)* | 3.55 | Australia | 353 | 365 | DISC-IV | 2014 | 16 | Second Australian Child and Adolescent Survey of Health and Well-being | 2 | 1 | 3 | |
Zubrick et al. (2016)* | 2.08 | Australia | 325 | 309 | DISC-IV | 2014 | 17 | Second Australian Child and Adolescent Survey of Health and Well-being | 2 | 1 | 3 |
Note. Sample = sample name (not all samples had a name); Interview = diagnostic interview used; OR = untransformed Odds Ratio; NM = n males; NF = n females; Year = year of data collection; Age = age or age range (in years); E = ethnicity (only applies to U.S. samples): 1 = mixed, 2 = > 85% Caucasian, 3 = > 85% African American, 4 = > 85% Asian American, 5 = > 85% Hispanic, 6 = > 85% Native American; F = focus of article: 1 = gender, 2 = depression, 3 = other, no value = no title; M = diagnostic manual or classification system: 1 = DSM-IV or DSM-IV-TR; 2 = DSM-III or DSM-III-R; 3 = ICD-10; T = time span during which depression was diagnosed: 0 = current; 1 = 1 month, 2 = 6 months, 3 = 12 months, 4 = lifetime;
= received additional data from author;
= World Mental Health Survey Sample;
= ICD-10 depressive episode (all other diagnoses were major depressive episodes or major depressive disorders);
DIS = Diagnostic Interview Schedule (Robins et al., 1981); CIDI = Composite International Diagnostic Interview (World Health Organization, 1990, 1997; Smeets & Dingemans, 1993); WMH- CIDI = World Mental Health CIDI or CIDI 3.0 (Kessler & Ustun, 2004); CIDI-SF = CIDI- Short Form (Kessler et al., 1998); K-CIDI = Korean version of the CIDI (Cho et al., 2002); M-CIDI = German version of the CIDI (Wittchen & Pfister, 1997); DAWBA = Development and Well-Being Assessment (Goodman et al., 2000); AUDADIS = Alcohol Use Disorder and Associated Disabilities Interview Schedule (Grant et al., 2001); MINI = Mini-International Neuropsychiatric Interview (Sheehan et al., 1998); NIMH DISC-IV = National Institute of Mental Health Diagnostic Interview Schedule for Children Version IV (Shaffer et al., 2000); SADS = Schedule of Affective Disorders and Schizophrenia (Endicott & Spitzer, 1978); WHO WHS = World Health Organization World Health Survey- 2002 (World Health Organization, 2002); SCID = Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-IV Axis I Disorders (First et al., 2002); CIS-R = Clinical Interview Schedule- Revised (Lewis et al., 1992); CIS = Clinical Interview Schedule (Lewis et al., 1992).